OLR1 and atherosclerosis: A previous study showed that LOX-1 alters ROS production, leading to lipid peroxidation and DNA damage, and promotes atherosclerosis and cancer progression, suggesting that LOX-1 inhibition may be a promising therapeutic strategy [42].